Ticker
TRVICompany Name
TREVI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -19.82% | $ 888.97M | $ 176.21M |
3/31/2025 | -10.51% | $ 671.52M | $ 70.54M |
12/31/2024 | -9.71% | $ 634.24M | $ 61.61M |
9/30/2024 | -4.26% | $ 238.28M | $ 10.15M |
6/30/2024 | -3.37% | $ 203.26M | $ 6.85M |
3/31/2024 | -0.88% | $ 204.26M | $ 1.79M |
12/31/2023 | -0.76% | $ 244.12M | $ 1.85M |
9/30/2023 | -4.91% | $ 86.53M | $ 4.25M |
6/30/2023 | -39.15% | $ 152.6M | $ 59.75M |
3/31/2023 | -65.17% | $ 180.21M | $ 117.45M |
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for TREVI THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 2.48M ]) / Market Cap [ $ 64.33M ]
(=) Buyback Yield [ -3.85% ]
Minimum
Sep 30, 2022
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.7% |